Alnylam Pharmaceuticals Inc (ALNY) Insider Trading
- $71,277,732.32
- $464,925,039.46
- March 3, 2026
- Akshay Vaishnaw
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 4, 2023 | CFO | 3,460 | $185.85 | Sell | $643,041.00 | |
| April 27, 2023 | CMO | 1,839 | $194.59 | Sell | $357,851.01 | |
| April 27, 2023 | EVP | 1,476 | $194.59 | Sell | $287,214.84 | |
| April 27, 2023 | CEO | 7,615 | $194.59 | Sell | $1,481,802.85 | |
| April 27, 2023 | President | 2,392 | $194.59 | Sell | $465,459.28 | |
| April 27, 2023 | CFO | 977 | $194.59 | Sell | $190,114.43 | |
| April 6, 2023 | EVP | 3,500 | $210.00 | Sell | $735,000.00 | |
| March 3, 2023 | CMO | 18,072 | $200.00 | Sell | $3,614,400.00 | |
| Feb. 2, 2023 | EVP | 1,675 | $226.01 | Sell | $378,566.75 | |
| Aug. 5, 2022 | EVP | 1,841 | $218.16 | Sell | $401,632.56 | |
| Aug. 3, 2022 | EVP | 1,754 | $210.00 | Sell | $368,340.00 | |
| July 5, 2022 | EVP | 1,754 | $150.00 | Sell | $263,100.00 | |
| April 1, 2022 | Director | 15,000 | $170.69 | Sell | $2,560,350.00 | |
| Dec. 23, 2021 | Insider | 2,879 | $190.93 | Sell | $549,687.47 | |
| Nov. 12, 2021 | CEO | 33,978 | $171.52 | Sell | $5,827,906.56 | |
| Aug. 13, 2021 | CEO | 33,979 | $199.78 | Sell | $6,788,324.62 | |
| Aug. 6, 2021 | COO | 53,064 | $199.00 | Sell | $10,559,736.00 | |
| Aug. 5, 2021 | EVP | 10,000 | $188.95 | Sell | $1,889,500.00 | |
| July 12, 2021 | EVP | 6,812 | $178.96 | Sell | $1,219,075.52 | |
| June 18, 2021 | Insider | 14,708 | $175.00 | Sell | $2,573,900.00 | |
| June 9, 2021 | EVP | 1,734 | $154.00 | Sell | $267,036.00 | |
| May 13, 2021 | CEO | 33,979 | $130.78 | Sell | $4,443,773.62 | |
| April 21, 2021 | Insider | 2,732 | $136.95 | Sell | $374,147.40 | |
| April 19, 2021 | Insider | 3,706 | $137.67 | Sell | $510,205.02 | |
| Jan. 12, 2021 | EVP | 14,941 | $160.20 | Sell | $2,393,548.20 | |
| Jan. 12, 2021 | COO | 3,125 | $161.00 | Sell | $503,125.00 | |
| Dec. 18, 2020 | Director | 15,000 | $140.00 | Sell | $2,100,000.00 | |
| Nov. 25, 2020 | Director | 30,000 | $124.89 | Sell | $3,746,700.00 | |
| Sept. 29, 2020 | Insider | 971 | $140.00 | Sell | $135,940.00 | |
| Sept. 9, 2020 | President | 44,530 | $123.23 | Sell | $5,487,431.90 | |
| Aug. 20, 2020 | CEO | 34,765 | $136.13 | Sell | $4,732,559.45 | |
| July 13, 2020 | EVP | 47,250 | $160.67 | Sell | $7,591,657.50 | |
| July 9, 2020 | COO | 11,236 | $161.00 | Sell | $1,808,996.00 | |
| July 7, 2020 | President | 22,265 | $159.99 | Sell | $3,562,177.35 | |
| May 20, 2020 | CEO | 34,765 | $143.22 | Sell | $4,979,043.30 | |
| May 6, 2020 | President | 22,265 | $149.99 | Sell | $3,339,527.35 | |
| May 5, 2020 | COO | 7,811 | $140.00 | Sell | $1,093,540.00 | |
| April 20, 2020 | Insider | 21,971 | $140.00 | Sell | $3,075,940.00 | |
| April 20, 2020 | EVP | 10,000 | $139.00 | Sell | $1,390,000.00 | |
| Feb. 20, 2020 | CEO | 34,765 | $131.85 | Sell | $4,583,765.25 | |
| Feb. 10, 2020 | COO | 9,892 | $130.00 | Sell | $1,285,960.00 | |
| Feb. 10, 2020 | Director | 30,000 | $130.00 | Sell | $3,900,000.00 | |
| Feb. 7, 2020 | Insider | 23,708 | $125.00 | Sell | $2,963,500.00 | |
| Feb. 7, 2020 | COO | 6,250 | $123.90 | Sell | $774,375.00 | |
| Jan. 29, 2020 | EVP | 6,337 | $119.00 | Sell | $754,103.00 | |
| Jan. 27, 2020 | EVP | 41,037 | $117.70 | Sell | $4,830,054.90 | |
| Nov. 20, 2019 | Director | 75,000 | $100.00 | Sell | $7,500,000.00 | |
| Nov. 20, 2019 | COO | 8,404 | $105.00 | Sell | $882,420.00 | |
| Nov. 18, 2019 | Director | 15,000 | $91.71 | Sell | $1,375,650.00 | |
| Oct. 22, 2019 | President | 58,913 | $89.99 | Sell | $5,301,580.87 |
Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.
The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Yvonne Greenstreet, Pushkal Garg, Laurie Keating, Barry E Greene, Tolga Tanguler, Kevin Joseph Fitzgerald, Jeffrey V Poulton, Philip A Sharp, Michael Mason, Paul Schimmel, Dennis A Ausiello, Laurence Reid, Michael W Bonney, Sanofi, Steven M Paul, Kevin P Starr, Phillip A Sharp, Indrani Lall Franchini, David E I Pyott, Amy W Schulman, David-Alexandre C Gros, John Clarke, Kevin P. Starr, Marsha Fanucci, Philip A. Sharp, Phillip A. Sharp, and Colleen F Reitan
The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.
John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.
Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.
The most recent insider trade for Alnylam Pharmaceuticals Inc was on March 3, 2026.
The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.
The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Pushkal Garg with a total value of $14,988,720.00 on Jan. 27, 2025.
